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Objectives: Respiratory epithelial cells convert inactive 25-hydroxyvitamin D3
(25OHD3) to its active form. The active 1,25-dihydroxyvitamin D [1,25(OH)2D]
induces the expression of the antimicrobial peptide cathelicidin (LL-37) and
suppresses the production of pro inﬂammatory cytokines. Cystic ﬁbrosis (CF) is
characterized by a vicious circle of infection and inﬂammation in the lungs. We
aimed to assess the ability of CF bronchial epithelial cells (CFBE) to convert
inactive 25OHD3 to the active 1,25(OH)2D and its impact on LL-37 production.
Methods: Human bronchial epithelial cells (HBE) and CFBE cells were seeded in
protein-coated plates and grown for 22 or 48 hours, when 25OHD3 was added to the
media (100 nmol/L). After one day of incubation, media was harvested. 1,25(OH)2D
and LL-37 concentrations were measured by EIA and ELISA, respectively.
Results: Adding 25OHD3 increased the concentration of 1,25(OH)2D in the media
from both HBE and CFBE cells. However, the amplitude of the increase was
signiﬁcantly lower in CFBE cells (12.0±8.0 pmol/L) compared to HBE cells
(33.2±12.4 pmol/L), p< 0.01. The LL-37 concentration in media from HBE or
CFBE cells did not change upon 25OHD3 treatment.
Conclusion: CFBE cells activate vitamin D with a signiﬁcantly lower efﬁcacy than
HBE cells. The data indicates that the ability to activate vitamin D may be impaired
in CFBE cells. This may translate into lower local active vitamin D concentrations
and contribute to the dysregulated immune response and the increased infection
susceptibility in CF lungs. More experiments using other cell lines and primary
epithelial cells are needed to conﬁrm these ﬁndings.
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Background: UK CF guidelines recommend serum 25-OH Vitamin D (25-OHD)
levels are maintained at 75–150 nmol/l to help prevent CF bone disease. To achieve
this, the CF unit at Great Ormond Street Hospital, London (GOS) has monitored and
sequentially increased Vitamin D supplementation over the last 10 years. Since 2010
our protocol is to supplement 1500–3000IU cholecalciferol daily for 12 weeks for
25-OHD levels <50 nmol/l, then re-check serum levels. If levels remain <50 nmol/l,
high dose supplementation is continued and levels reviewed 3 monthly.
Objectives: To determine the prevalence of sub-optimal serum 25-OHD levels in
our CF paediatric population in response to increased supplementation protocols
over a 10 year period.
Methods: Retrospective interrogation of all patients on the GOS CF database with
a serum 25-OHD level measured at their annual review from 2003–2012.
Results: See the table.
Table: GOS Serum 25-OHD levels 2003–2012
Year of
annual review
No. of
patients
Mean (SD)
25-OHD (nmol/l)
Daily vitamin D
supplementation (IU)
N (%) with
25-OHD >75 nmol/l
2003 148 50 (17) 400–600 12 (8)
2005 128 51 (17) 400–2000 11 (9)
2007 144 49 (17) 400–2000 11 (8)
2009 136 65 (29) 400–2000 43 (32)
2012 144 78 (27) 400–3000 83 (58)
The proportion of patients with a 25-OHD >75 nmol/l increased signiﬁcantly. By
2012, 83 (58%) patients had a vitamin D level >75 nmol/l compared to only
12 (8%) in 2003 (p< 0.0001).
Conclusion: In the last decade we have observed a signiﬁcant increase in mean
vitamin D levels paralleling changes in supplementation protocols. Despite this,
42% of our population are yet to achieve serum 25-OHD levels >75 nmol/l. Our
current regimen will need to be reviewed again to improve this further.
